Breast Cancer Clinical Trials in High Point, NC

Breast Cancer Clinical Trials in High Point, NC

View the best 10 breast cancer medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in High Point, North Carolina

Here are the top 10 medical studies for breast cancer in High Point, North Carolina

Image of Carle Cancer Center in Urbana, United States.

Denosumab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing whether denosumab can prevent breast cancer in women with a BRCA1 gene mutation, which is linked to a higher risk of developing the disease.
Image of University of Rochester NCORP Research Base in Rochester, United States.

Netupitant/Palonosetron Hydrochloride

NK1 Receptor Antagonist

Recruiting1 awardPhase 3
This trial will compare netupitant/palonosetron hydrochloride and dexamethasone with prochlorperazine or olanzapine to see if they are more effective in improving chemotherapy-induced nausea and vomiting in patients with breast cancer.
Image of UC Irvine Health/Chao Family Comprehensive Cancer Center in Orange, United States.

Nab-paclitaxel +2 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing how well a combination of chemotherapy drugs, immunotherapy drugs, and a personalized vaccine work in treating patients with metastatic triple negative breast cancer.
Image of Sidney Kimmel Comprehensive Cancer Center in Baltimore, United States.

High-dose Methotrexate

Anti-metabolites

Recruiting1 awardPhase 2
This trial is testing the use of high-dose methotrexate to treat leptomeningeal disease (LMD) in patients with metastatic breast cancer. LMD is a cancer that has spread to the thin layer of tissue that covers the brain and spinal cord. There is no cure for LMD, and it is a difficult disease to treat because it is hard to reach with traditional cancer treatments. HD-MTX is a chemotherapy drug that has been shown to be effective against breast cancer, and it is hoped that it will be effective against LMD as well. This study is being done to see if HD-MTX is
Image of Banner MD Anderson Cancer Center in Gilbert, United States.

NBTXR3 +2 More

Nanoparticle

Recruiting1 awardPhase 1
This trial is testing a new cancer treatment that involves injecting a drug directly into tumors and combining it with anti-PD-1 therapy. The goal is to see if this is a safe and effective treatment for cancer.
Image of UAB Comprehensive Cancer Center in Birmingham, United States.

Fulvestrant +2 More

Selective Estrogen Receptor Downregulator

Recruiting1 awardPhase 2
This trial is studying whether fulvestrant is more effective than anastrozole or tamoxifen in reducing Ki67 in ILC and whether that Ki67 reduction will correlate with alterations in expression of ER and ER-regulated genes.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Surgery +2 More

Procedure

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Image of University of California, San Francisco in San Francisco, United States.

Atorvastatin +1 More

HMG-CoA reductase inhibitor

Recruiting2 awardsPhase 2
This trial is testing whether the cholesterol-lowering medication atorvastatin can reduce the risk of breast cancer.
Image of University of Colorado in Aurora, United States.

CAB-ROR2-ADC

Antibody-drug conjugate

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug to see if it is safe and effective.
Image of Radiation Oncology, Duke University Medical Center in Durham, United States.

Doxil

Anti-tumor antibiotic

Recruiting1 awardPhase 2
This trial is for patients with recurrent breast cancer located on the chestwall or metastatic breast cancer.

Popular filter options for breast-cancer high-point trials

Phase 3 Clinical Trials

View 99 phase 3 medical studies.

Clinical Trials With No Placebo

View 99 medical studies that do not have a placebo group.

View More Breast-cancer High-point Trials

See another 84 medical studies focused on breast-cancer high-point.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.